IFNA1 and COVID-19: These results are corroborated by previous studies indicating that anti-IFN IgG in COVID-19 are mainly directed against type I IFNs and that these autoantibodies typically existed prior to COVID-191, although results suggesting new-onset anti-IFN antibodies have also been reported39.